Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service mechanical circulatory support cases in North Carolina: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 9% on average (146 state-years, 2020–2024): read it as a direction with a margin.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 2 | 725 | 40% |
| 2020 | 1 | 632 | 43% |
| 2021 | 3 | 645 | 48% |
| 2022 | 1 | 598 | 52% |
| 2023 | 0 | 504 | 56% |
| 2024 | 1 | 534 | 59% |
| 2025 from claims | – | 541 437–635 | 61% |
| 2026 forecast | – | 544 426–683 | 62% |
| 2027 forecast | – | 545 404–721 | 62% |
| 2028 forecast | – | 546 386–753 | 63% |
| 2029 forecast | – | 546 371–783 | 64% |
| 2030 forecast | – | 546 358–811 | 65% |
Percutaneous ventricular assist and intra-aortic balloon pump. Professional codes (what the surgeon bills): CPT 33990, 33991, 33995, 33967, 33970; the hospital bills MS-DRG 268, 269.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in North Carolina; 1 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 100% inpatient hospital.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Texas | 2 | 1,476−3.6%/yr | −3.6%/yr | 0.7 | 0% | 2,210 in 2030+6.9%/yr |
| Florida | 5 | 1,323−3.5%/yr | −3.5%/yr | 0.6 | 0% | 1,380 in 2030+0.8%/yr |
| Tennessee | 2 | 492−1.4%/yr | −1.4%/yr | 0.7 | 0% | 420 in 2030−2.5%/yr |
| Georgia | 0 | 422−6.1%/yr | −6.1%/yr | 0.5 | 0% | 500 in 2030+3%/yr |
| Virginia | 1 | 392−3.6%/yr | −3.6%/yr | 0.4 | 0% | 450 in 2030+2.2%/yr |
| Maryland | 5 | 360−2%/yr | −2%/yr | 0.4 | 0% | 350 in 2030−0.6%/yr |
| Louisiana | 0 | 290−8.2%/yr | −8.2%/yr | 0.7 | 0% | 300 in 2030+0.7%/yr |
| Kentucky | 0 | 264−6.4%/yr | −6.4%/yr | 0.6 | 0% | 220 in 2030−2.9%/yr |
| South Carolina | 0 | 256−4.4%/yr | −4.4%/yr | 0.4 | 0% | 300 in 2030+2.7%/yr |
| Alabama | 1 | 254−13%/yr | −13%/yr | 0.6 | 0% | 240 in 2030−1.3%/yr |
| Arkansas | 0 | 234−12%/yr | −12%/yr | 0.6 | 0% | 250 in 2030+1.1%/yr |
| Oklahoma | 0 | 231−9.9%/yr | −9.9%/yr | 0.5 | 0% | 240 in 2030+0.7%/yr |
| Mississippi | 0 | 161−10%/yr | −10%/yr | 0.4 | 0% | 180 in 2030+1.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 124 | 5,638−9.6%/yr | −9.6%/yr | 4.60.7× | 0% | 6,040 in 2030+1.2%/yr |
| Structural heart (TAVR, TEER) | 75 | 1,460−1.4%/yr | −1.4%/yr | 1.20.8× | 0% | 2,070 in 2030+6%/yr |
Mechanical circulatory support in every state, and its device makers · Every procedure market in North Carolina · Every state · Compare with Texas
Briohealth Solutions leads with 89% of company spending on these surgeons in 2025, +89 pts on 2024.
In 2025, 2 companies reported engagement with North Carolina’s surgeons worth $2,753 in consulting, speaking, meals and travel tied to these products, about $2,753 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 48 clearances and approvals in the category, 7 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.
For MS-DRG 269 (aortic and heart assist procedures except pulsation balloon without mcc), commercial plans pay North Carolina’s hospitals a median of $67K, from $58K at the lowest to $67K at the highest, across 8 hospitals that publish a price.
Each hospital’s median over its commercial plans, from the machine-readable files hospitals must post; not every hospital is loaded.